Interestingly, the CYP27A1 expression level is inversely correlated to prostate cancer development and progression [79], while the CYP7B1 enzyme level is significantly upregulated during prostate cancer prognosis [90], suggesting that 27HC might be actually beneficial against prostate cancer. The gene discussed is CYP7B1; the disease is prostate carcinoma.